Biora Therapeutics Inc
NASDAQ:BIOR

Watchlist Manager
Biora Therapeutics Inc Logo
Biora Therapeutics Inc
NASDAQ:BIOR
Watchlist
Price: 0.22 USD Market Closed
Market Cap: $994.4k

Profitability Summary

Biora Therapeutics Inc's profitability score is 32/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

32 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

32 / 100
Profitability
Score
32 / 100
Profitability
Score

Margins

Earnings Waterfall
Biora Therapeutics Inc

Margins Comparison
Biora Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Biora Therapeutics Inc
NASDAQ:BIOR
994.4k USD
Loading...
Loading...
US
CVS Health Corp
NYSE:CVS
95.3B USD
Loading...
Loading...
US
Cigna Group
XMUN:CGN
68B EUR
Loading...
Loading...
US
Cigna Corp
NYSE:CI
70.8B USD
Loading...
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.8B EUR
Loading...
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
23.2B EUR
Loading...
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
21.9B USD
Loading...
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.1B USD
Loading...
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
Loading...
US
Guardant Health Inc
NASDAQ:GH
11.1B USD
Loading...
Loading...
US
DaVita Inc
NYSE:DVA
9.9B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Biora Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Biora Therapeutics Inc
NASDAQ:BIOR
994.4k USD
Loading...
Loading...
Loading...
Loading...
US
CVS Health Corp
NYSE:CVS
95.3B USD
Loading...
Loading...
Loading...
Loading...
US
Cigna Group
XMUN:CGN
68B EUR
Loading...
Loading...
Loading...
Loading...
US
Cigna Corp
NYSE:CI
70.8B USD
Loading...
Loading...
Loading...
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.8B EUR
Loading...
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
23.2B EUR
Loading...
Loading...
Loading...
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
21.9B USD
Loading...
Loading...
Loading...
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.1B USD
Loading...
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
Loading...
Loading...
Loading...
US
Guardant Health Inc
NASDAQ:GH
11.1B USD
Loading...
Loading...
Loading...
Loading...
US
DaVita Inc
NYSE:DVA
9.9B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Biora Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett